SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (839)7/19/1999 11:34:00 AM
From: kech  Read Replies (2) of 2001
 
There are a couple of good references to competition from Genzyme's Seprafilm back in May and April. From what i can tell, Seprafilm has some disadvantages because it is in "film" form and has to be wrapped around organs in abdominal surgery. A gel product like Adcon-P wouldn't need to do this. However, what keeps Genzyme from coming out with SepraGel? Are they planning to do this? What impact would it have on Gliatech? Are there other advantages of the ADCON product besides its gel form that would make it more successful in abdominal or pelvis surgeries compared to either the current SepraFilm or the possible arrival of a SepraGel? Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News